Copyright
©The Author(s) 2018.
World J Gastroenterol. Nov 21, 2018; 24(43): 4939-4949
Published online Nov 21, 2018. doi: 10.3748/wjg.v24.i43.4939
Published online Nov 21, 2018. doi: 10.3748/wjg.v24.i43.4939
Figure 3 Kaplan-Meier plots of recurrent primary sclerosing cholangitis-free survival in patients with pre-orthotopic liver transplantation inflammatory bowel disease (blue line) and de novo inflammatory bowel disease (red line).
- Citation: Bajer L, Slavcev A, Macinga P, Sticova E, Brezina J, Roder M, Janousek R, Trunecka P, Spicak J, Drastich P. Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease. World J Gastroenterol 2018; 24(43): 4939-4949
- URL: https://www.wjgnet.com/1007-9327/full/v24/i43/4939.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i43.4939